Thorough QT Study to Evaluate the Effect of Rodatristat Ethyl, Rodatristat and Its Major Metabolites on the Heart
Clinical trial NCT05933447 · COMPLETED
Trial details
- NCT number
- NCT05933447
- Sponsor
- Altavant Sciences GmbH
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-12
- Primary completion
- 2023-07-28
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.